Cargando…

Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache

BACKGROUND: Medication-overuse headache (MOH) is a chronic disorder that results from the overuse of analgesics drugs, triptans or other acute headache compounds. Although the exact mechanisms underlying MOH remain still unknown, several studies suggest that it may be associated with development of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bellei, Elisa, Monari, Emanuela, Bergamini, Stefania, Cuoghi, Aurora, Tomasi, Aldo, Guerzoni, Simona, Ciccarese, Michela, Pini, Luigi Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536253/ https://www.ncbi.nlm.nih.gov/pubmed/26272683 http://dx.doi.org/10.1186/s10194-015-0559-8

Ejemplares similares

Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache
por: Bellei, Elisa, et al.
Publicado: (2013)

Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages
por: Bellei, Elisa, et al.
Publicado: (2011)

Urinary Proteomics in Biomarker Discovery of Kidney-Related Disorders: Diabetic Nephropathy and Drug-Induced Nephrotoxicity in Chronic Headache
por: Bellei, Elisa, et al.
Publicado: (2018)

Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication–overuse headache
por: Pellesi, Lanfranco, et al.
Publicado: (2019)

Proteomic research of proteins involved in pain expression in an animal model of chronic pain
por: Bellei, Elisa, et al.
Publicado: (2015)

Serum protein changes in a rat model of chronic pain show a correlation between animal and humans
por: Bellei, Elisa, et al.
Publicado: (2017)

Analysis of protein expression in periodontal pocket tissue: a preliminary study
por: Monari, Emanuela, et al.
Publicado: (2015)

Enriched sera protein profiling for detection of non-small cell lung cancer biomarkers
por: Monari, Emanuela, et al.
Publicado: (2011)

Inflammation: an important parameter in the search of prostate cancer biomarkers
por: Bergamini, Stefania, et al.
Publicado: (2014)

Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial
por: Pini, Luigi Alberto, et al.
Publicado: (2012)

Discovery of restless legs syndrome plasmatic biomarkers by proteomic analysis
por: Bellei, Elisa, et al.
Publicado: (2018)

Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study
por: Rustichelli, Cecilia, et al.
Publicado: (2020)

Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study
por: Rustichelli, Cecilia, et al.
Publicado: (2021)

Urinary Proteomics Reveals Promising Biomarkers in Menstrually Related and Post-Menopause Migraine
por: Bellei, Elisa, et al.
Publicado: (2021)

Proteomic Analysis of PTCH1+/− Fibroblast Lysate and Conditioned Culture Media Isolated from the Skin of Healthy Subjects and Nevoid Basal Cell Carcinoma Syndrome Patients
por: Ponti, Giovanni, et al.
Publicado: (2013)

Proteomics Disclose the Potential of Gingival Crevicular Fluid (GCF) as a Source of Biomarkers for Severe Periodontitis
por: Bellei, Elisa, et al.
Publicado: (2022)

P045. OnabotulinumtoxinA: long term treatment for chronic migraine with medication overuse
por: Guerzoni, Simona, et al.
Publicado: (2015)

Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
por: Guerzoni, Simona, et al.
Publicado: (2017)

Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey
por: Ferrari, Anna, et al.
Publicado: (2013)

Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
por: Guerzoni, Simona, et al.
Publicado: (2018)

A Proteomic Analysis of Discolored Tooth Surfaces after the Use of 0.12% Chlorhexidine (CHX) Mouthwash and CHX Provided with an Anti-Discoloration System (ADS)
por: Bergamini, Stefania, et al.
Publicado: (2021)

Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid Review
por: Lo Castro, Flavia, et al.
Publicado: (2021)

Galcanezumab for the treatment of chronic migraine and medication overuse headache: Real‐world clinical evidence in a severely impaired patient population
por: Guerzoni, Simona, et al.
Publicado: (2023)

Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache
por: Pensato, Umberto, et al.
Publicado: (2022)

Research of Prostate Cancer Urinary Diagnostic Biomarkers by Proteomics: The Noteworthy Influence of Inflammation
por: Bellei, Elisa, et al.
Publicado: (2023)

Candidate Genes and Proteomic Biomarkers of Serum and Urine in Medication-Overuse Headache
por: Shnayder, Natalia A., et al.
Publicado: (2021)

Basal cutaneous pain threshold in headache patients
por: Zappaterra, Maurizio, et al.
Publicado: (2011)

Medication-overuse headache: an update
por: Sarchielli, Paola
Publicado: (2015)

Withdrawal failure in patients with chronic migraine and medication overuse headache
por: D’Amico, Domenico, et al.
Publicado: (2021)

Medication–overuse headache: pathophysiological insights
por: Calabresi, P., et al.
Publicado: (2005)

Medication-overuse headache: a review
por: Kristoffersen, Espen Saxhaug, et al.
Publicado: (2014)

Preventing and treating medication overuse headache
por: Alstadhaug, Karl B., et al.
Publicado: (2017)

Treatment of withdrawal headache in patients with medication overuse headache: a pilot study
por: Cevoli, Sabina, et al.
Publicado: (2017)

Comparison of tolerability and efficacy of a combination of paracetamol + caffeine and sumatriptan in the treatment of migraine attack: a randomized, double-blind, double-dummy, cross-over study
por: Pini, Luigi Alberto, et al.
Publicado: (2012)

Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline
por: Diener, Hans-Christoph, et al.
Publicado: (2022)

Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal
por: Baraldi, Carlo, et al.
Publicado: (2017)

Lack of association between five serotonin metabolism-related genes and medication overuse headache
por: Cevoli, Sabina, et al.
Publicado: (2009)

Abnormal cortical responses to somatosensory stimulation in medication-overuse headache
por: Coppola, Gianluca, et al.
Publicado: (2010)

Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic
por: Baraldi, Carlo, et al.
Publicado: (2021)

Treatment and outcome in medication overuse headache patients
por: Mitsikostas, D, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jpuq9cdg1ram4pc985gqvq2aff